Epigallocatechin gallate inhibits SNARE‐dependent membrane fusion by blocking trans‐SNARE assembly

Insulin secretion is a signal‐triggered process that requires membrane fusion between the secretory granules and plasma membrane in pancreatic β cells. The exocytosis of insulin is mediated by target‐soluble N‐ethylmaleimide sensitive factor attachment protein receptors (SNAREs) on the plasma membrane and vesicle‐SNAREs on the vesicles, which assemble into a quaternary trans‐SNARE complex to initiate the fusion. Expression of fusion proteins is reduced in the islets of patients with type II diabetes, indicating that SNARE‐mediated fusion defect is closely related to insulin‐based metabolic diseases. Previous studies have suggested that epigallocatechin gallate (EGCG) has an inhibitory effect on membrane fusion. In the present study, we performed in vitro reconstitution assays to unravel the molecular mechanisms of EGCG in SNARE‐mediated insulin secretory vesicle fusion. Our data show that EGCG efficiently inhibits insulin secretory SNARE‐mediated membrane fusion. Mechanistic studies indicated that EGCG blocks the formation of the trans‐SNARE complex. Furthermore, calcium/synaptotagmin‐7‐stimulated fusion kinetics were largely reduced by EGCG, confirming that it is a potential regulator of SNARE‐dependent insulin secretion. Our findings suggest that the trans‐SNARE complex might be a promising target for controlling SNARE‐dependent vesicle fusion. Insulin secretion is mediated by soluble N‐ethylmaleimide sensitive factor attachment protein receptor (SNARE)‐dependent membrane fusion. In the present study, we show that epigallocatechin gallate, a polyphenol compound, efficiently inhibited the insulin secretory SNARE‐mediated membrane fusion by blocking the formation of the trans‐SNARE complex. Our findings suggest that the trans‐SNARE complex might be a promising target for controlling vesicle fusion during exocytosis.